GenSight Biologics S.A.

ENXTPA:SIGHT Stock Report

Market Cap: €35.7m

GenSight Biologics Balance Sheet Health

Financial Health criteria checks 0/6

GenSight Biologics has a total shareholder equity of €-24.8M and total debt of €21.2M, which brings its debt-to-equity ratio to -85.5%. Its total assets and total liabilities are €15.0M and €39.8M respectively.

Key information

-85.5%

Debt to equity ratio

€21.24m

Debt

Interest coverage ration/a
Cash€6.94m
Equity-€24.83m
Total liabilities€39.82m
Total assets€14.99m

Recent financial health updates

Recent updates

Is There An Opportunity With GenSight Biologics S.A.'s (EPA:SIGHT) 30% Undervaluation?

Dec 22
Is There An Opportunity With GenSight Biologics S.A.'s (EPA:SIGHT) 30% Undervaluation?

Is GenSight Biologics S.A. (EPA:SIGHT) Trading At A 39% Discount?

Sep 20
Is GenSight Biologics S.A. (EPA:SIGHT) Trading At A 39% Discount?

Health Check: How Prudently Does GenSight Biologics (EPA:SIGHT) Use Debt?

Aug 17
Health Check: How Prudently Does GenSight Biologics (EPA:SIGHT) Use Debt?

Rock star Growth Puts GenSight Biologics (EPA:SIGHT) In A Position To Use Debt

Aug 04
Rock star Growth Puts GenSight Biologics (EPA:SIGHT) In A Position To Use Debt

GenSight Biologics S.A. (EPA:SIGHT) Shares Could Be 27% Below Their Intrinsic Value Estimate

Jun 14
GenSight Biologics S.A. (EPA:SIGHT) Shares Could Be 27% Below Their Intrinsic Value Estimate

GenSight Biologics S.A. (EPA:SIGHT): Is Breakeven Near?

May 10
GenSight Biologics S.A. (EPA:SIGHT): Is Breakeven Near?

Analysts Expect Breakeven For GenSight Biologics S.A. (EPA:SIGHT) Before Long

Feb 02
Analysts Expect Breakeven For GenSight Biologics S.A. (EPA:SIGHT) Before Long

A Quick Analysis On GenSight Biologics' (EPA:SIGHT) CEO Salary

Dec 09
A Quick Analysis On GenSight Biologics' (EPA:SIGHT) CEO Salary

Financial Position Analysis

Short Term Liabilities: SIGHT has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: SIGHT has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: SIGHT has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: SIGHT's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SIGHT has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: SIGHT has less than a year of cash runway if free cash flow continues to grow at historical rates of 0.9% each year.


Discover healthy companies